References
- Gisler R. H., Dietrich F. M., Bachang G., Brownbill A., Schumann G., Staber F. G., Tarcsay L., Wachsmuth E. D., Dukor P. Drugs and Immune Responsiveness, J. L. Turk, D. Parker. Mac Millan Press, New York 1979; 133
- Mathé G. Active immunotherapy by B.C.G. Adv. Cancer Res. 1971; 14: 1
- Goodnight J. E., Morton D. L. Immunotherapy for malignant disease. Ann. Rev. Med. 1978; 29: 231
- Fischer B., Rubin H., Sartiano G., Eunis L., Wolmark N. Observations following Corynebacterium parvum administration of patients with advanced malignancy: a phase I study. Cancer 1976; 38: 119
- Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 1974; 59: 317
- Jollès P. Hydrosoluble immunostimulants of bacterial and synthetic origin. Experientia 1976; 32: 677
- Jollès P. A possible physiological function of lysozyme. Biomedicine 1976; 25: 275
- Adam A., Ciorbaru R., Ellouz F., Petit J. F., Lederer E. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem. Biophys. Res. Commun. 1974; 56: 561
- Kotani S., Narita T., Stewart-Tull D. E.S., Shimono T., Watanabe Y., Kato K., Iwata S. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria. Biken. J. 1975; 18: 77
- Migliore-Samour D., Jollès P. Hydrosoluble adjuvantactive mycobacterial fractions of low molecular weight. FEBS Letters 1973; 35: 317
- Alais C., Jollès P. Human casein and its caseinogly-copeptide. Nature 1962; 196: 1098
- Klesius P. H. A rapid method for in vitro screening of immunosuppressants using mouse spleen cells. Proc. Soc. exp. Biol. Pled. (N.Y.) 1970; 135: 155
- van Dijk H., Bloksma N. Quantification of in vitro antibody secretion by immune spleen cells. J. Immunol. Methods 1977; 14: 325